MedTrace Logo

Metabolomic Study of All-age Cardiomyopathy

NCT03061994 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2017-05-30

No results posted yet for this study

Summary

This study aims to 1)characterize the differentially expressed metabolites between cardiomyopathy patients and healthy controls,2)identify the specific biomarkers associated with outcomes or risk evaluation in patients with different cardiomyopathies in a follow-up of a cohort and 3)to determine whether differentially expressed may affect the pathological process of cardiomyopathies . Standardized protocols will be used for the assessment of medical history and examinations, laboratory biomarkers, and the collection of blood plasma.

Conditions

  • Dilated Cardiomyopathy
  • Hypertrophic Cardiomyopathy
  • Arrhythmogenic Right Ventricular Cardiomyopathy
  • Left Ventricular Non-compaction
  • Restrictive Cardiomyopathy

Sponsors & Collaborators

  • Beijing Institute of Heart, Lung and Blood Vessel Diseases

    lead OTHER

Principal Investigators

  • Yulin Li, PhD · Beijing anzhen hospital affiliated to capital medical university

  • Yongqiang Lai, MD · Beijing anzhen hospital affiliated to capital medical university

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2019-10-31
Completion
2020-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03061994 on ClinicalTrials.gov